Published in Pharma Law Weekly, March 21st, 2006
According to the review, "The importance of inflammation in the pathogenesis of atherosclerosis is well established. The vascular endothelium contributes to and is affected by the inflammatory process."
"For example," wrote A.L. Huang and J.A. Vita at Boston Medical Center, "a variety of cytokines have the ability to 'activate' the endothelium and thereby promote expression of adhesion molecules and chemotactic factors that accelerate the inflammatory...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
Source: Pharma Law Weekly (2006-03-21)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.